An observational study of 160,000 patients with diabetes taking GLP-1 drugs finds no heightened risk for retinopathy ...

In an era where chronic diseases are reshaping global health priorities, the diabetic retinopathy market stands out as a ...

Researchers have determined that the red cell distribution width-to-albumin ratio (RAR), a composite biomarker of systemic ...

In patients with diabetic macular edema in both eyes, the port delivery system in one eye achieves a superior anatomical ...

REGENXBIO Inc. (Nasdaq: RGNX) today announced it will initiate a pivotal Phase IIb/III clinical trial for investigational surabgene lomparvovec (sura-vec, ABBV-RGX-314) in diabetic retinopathy (DR) ...

Noticing spots or web-like shapes in your vision? Expert warns these common eye floaters might signal hidden health issues linked to serious conditions. Find out what you should watch for.

An intravitreal implant shows promise in enhancing visual function and retinal structure in diabetic retinopathy patients, ...

Diabetic retinopathy is the leading cause of blindness in working-age adults in the U.S. and is a complication of diabetes.

In a separate study, an implant containing a different investigational endothelin antagonist (PER-001) reduced macular ...

PER-001, delivered through a slow-release, dissolvable implant in the vitreous cavity of the eye, is designed to block ...

REGENXBIO Inc. announced it will initiate a pivotal phase IIb/III clinical trial for investigational surabgene lomparvovec (sura-vec, ABBV-RGX-314) in diabetic retinopathy (DR) using suprachoroidal ...

Exonate has announced plans to initiate a phase 2b clinical trial of its lead candidate EXN407, a topical SRPK1 inhibitor, ...